Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Who is a candidate, and who is not Inquire about preferred smoothness of recovery, four- to six-week daily self-injection capability and documented health history for tolerance
In the study published in Diabetes Technology & Therapeutics , participants experienced an average weight reduction of more than 23%, demonstrating the drugs effectiveness in managing obesity alongside T1D
Results are expected in December 2026
This article was originally published on 08.05.2025 and updated on 17.02.2026
US$ 20.03
US$ 24.99
US$ 28.79
US$ 22.41
)
US$ 29.77
US$ 26.70
)
